Login / Signup

2-Methacryloyloxyethyl phosphorylcholine (MPC)-polymer suppresses an increase of oral bacteria: a single-blind, crossover clinical trial.

Natsumi FujiwaraHiromichi YumotoKoji MiyamotoKatsuhiko HirotaHiromi NakaeSaya TanakaKeiji MurakamiYasusei KudoKazumi OzakiYoichiro Miyake
Published in: Clinical oral investigations (2018)
MPC-polymer can be a potent compound for the control of oral microflora to prevent oral infection.
Keyphrases
  • clinical trial
  • open label
  • signaling pathway
  • randomized controlled trial
  • study protocol
  • phase iii